Abdelmalek, Manal F.
University Hospitals Birmingham NHS Foundation Trust · Mayo Clinic · Inserm · Université Paris Cité · Sorbonne Université · University of Oxford · Centre de Recherche des Cordeliers · Centre de Recherche sur l'Inflammation · Physiopathologie et pharmacotoxicologie placentaire humaine : Microbiote pré & post natal · University of Birmingham · Newcastle University
41 papers on CoChatORCID 0000-0002-5001-8618
Most cited papers
- Verified
NKT-Associated Hedgehog and Osteopontin Drive Fibrogenesis in Non-Alcoholic Fatty Liver Disease
Syn, W.-K., Agboola, K. M., Swiderska, M., Michelotti, G. A., Liaskou, E., Pang, H., Xie, G., Philips, G., Chan, I. S., Karaca, G. F., et al. (2012) · Gut
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 266
- Verified
AGA clinical practice update on the role of noninvasive biomarkers in the evaluation and management of nonalcoholic fatty liver disease: expert review
Wattacheril, J. J., Abdelmalek, M. F., Lim, J. K., & Sanyal, A. J. (2023) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 236
- Verified
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
Ratziu, V., de Guevara, L., Safadi, R., Poordad, F., Fuster, F., Flores-Figueroa, J., Arrese, M., Fracanzani, A. L., Ben Bashat, D., Lackner, K., et al. (2021) · Nature Medicine
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 222
- Verified
Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: analysis of data from a phase II trial of selonsertib
Jayakumar, S., Middleton, M. S., Lawitz, E. J., Mantry, P. S., Caldwell, S. H., Arnold, H., Mae Diehl, A., Ghalib, R., Elkhashab, M., Abdelmalek, M. F., et al. (2019) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentUltrasound Imaging and Elastography
Cited by 208
- Verified
Increased production of sonic hedgehog by ballooned hepatocytes
Rangwala, F., Guy, C. D., Lu, J., Suzuki, A., Burchette, J. L., Abdelmalek, M. F., Chen, W., & Diehl, A. M. (2011) · The Journal of Pathology
Liver physiology and pathologyLiver Disease Diagnosis and Treatment
Cited by 201
- Verified
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
Abdelmalek, M. F., Lazo, M., Horska, A., Bonekamp, S., Lipkin, E. W., Balasubramanyam, A., Bantle, J. P., Johnson, R. J., Diehl, A. M., & Clark, J. M. (2012) · Hepatology
Diet, Metabolism, and DiseaseLiver Disease Diagnosis and Treatment
Cited by 190
- Verified
Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease
Youssef, N. A., Abdelmalek, M. F., Binks, M., Guy, C. D., Omenetti, A., Smith, A. D., Diehl, A. M. E., & Suzuki, A. (2013) · Liver International
Liver Disease Diagnosis and TreatmentAlcohol Consumption and Health Effects
Cited by 182
- Verified
Cenicriviroc lacked efficacy to treat liver fibrosis in nonalcoholic steatohepatitis: AURORA phase III randomized study
Anstee, Q. M., Neuschwander-Tetri, B. A., Wai-Sun Wong, V., Abdelmalek, M. F., Rodriguez-Araujo, G., Landgren, H., Park, G. S., Bedossa, P., Alkhouri, N., Tacke, F., et al. (2024) · Clinical Gastroenterology and Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 179
- Verified
Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
Sanyal, A. J., Anstee, Q. M., Trauner, M., Lawitz, E. J., Abdelmalek, M. F., Ding, D., Han, L., Jia, C., Huss, R. S., Chung, C., et al. (2022) · Hepatology
Liver Disease Diagnosis and TreatmentLiver Disease and Transplantation
Cited by 171
- Verified
Results from a new efficacy and safety analysis of the REGENERATE trial of obeticholic acid for treatment of pre-cirrhotic fibrosis due to non-alcoholic steatohepatitis
Sanyal, A. J., Ratziu, V., Loomba, R., Anstee, Q. M., Kowdley, K. V., Rinella, M. E., Sheikh, M. Y., Trotter, J. F., Knapple, W., Lawitz, E. J., et al. (2023) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 137
- Verified
Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis
Loomba, R., Ratziu, V., Harrison, S. A., Loomba, R., McFarlane, S. C., Tamaki, N., Ratziu, V., Abdelmalek, M. F., Rinella, M. E., Anstee, Q. M., et al. (2022) · Gastroenterology
Liver Disease Diagnosis and TreatmentStatistical Methods in Clinical Trials
Cited by 127
- Verified
Factors associated with histologic response in adult patients with nonalcoholic steatohepatitis
Loomba, R., Sanyal, A. J., Kowdley, K. V., Terrault, N., Chalasani, N. P., Abdelmalek, M. F., McCullough, A. J., Shringarpure, R., Ferguson, B., Lee, L., et al. (2019) · Gastroenterology
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 124
- Verified
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis
Loomba, R., Huang, D. Q., Sanyal, A. J., Anstee, Q. M., Trauner, M., Lawitz, E. J., Ding, D., Ma, L., Jia, C., Billin, A., et al. (2023) · Gut
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 110
- Verified
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH
Ratziu, V., Harrison, S. A., Loustaud-Ratti, V., Bureau, C., Lawitz, E., Abdelmalek, M., Alkhouri, N., Francque, S., Girma, H., Darteil, R., et al. (2023) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 101
- Verified
Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum
Glass, O., Filozof, C., Noureddin, M., Berner-Hansen, M., Schabel, E., Omokaro, S. O., Schattenberg, J. M., Barradas, K., Miller, V., Francque, S., et al. (2020) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity
Cited by 89
- Verified
Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity
Guy, C. D., Suzuki, A., Abdelmalek, M. F., Burchette, J. L., Diehl, A. M., & CRN, F. T. N. (2015) · Hepatology
Liver Disease Diagnosis and TreatmentLiver physiology and pathology
Cited by 72
- Verified
HM15211, a novel GLP-1/GIP/Glucagon triple-receptor co-agonist significantly reduces liver fat and body weight in obese subjects with non-alcoholic fatty liver disease: A Phase 1b/2a, multi-center, randomized, placebo-controlled trial
Abdelmalek, M., Choi, J., Kim, Y., Seo, K., Hompesch, M., & Baek, S. (2020) · Journal of Hepatology
Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management
Cited by 30
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free